Cited by 29

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Membrane cholesterol as regulator of human rhomboid protease RHBDL4.

Paschkowsky, Sandra, Recinto, Sherilyn Junelle, Young, Jason C., Bondar, Ana-Nicoleta, Munter, Lisa Marie·2018·Journal of Biological Chemistry

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.ra118.002640

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 52

  1. Lemberg, 2007, Functional and evolutionary implications of enhanced genomic analysis of rhomboid intramembrane proteases, Genome Res, 17, 1634, 10.1101/gr.6425307 · DOI
  2. Baker, 2006, Two Plasmodium rhomboid proteases preferentially cleave different adhesins implicated in all invasive stages of malaria, PLoS Pathog, 2, e113, 10.1371/journal.ppat.0020113 · DOI
  3. Shen, 2014, Functional analysis of rhomboid proteases during Toxoplasma invasion, MBio, 5, e01795, 10.1128/mBio.01795-14 · DOI
  4. Lemberg, 2016, Inactive rhomboid proteins: new mechanisms with implications in health and disease, Semin. Cell Dev. Biol, 60, 29, 10.1016/j.semcdb.2016.06.022 · DOI
  5. Spinazzi, 2016, PARL: the mitochondrial rhomboid protease, Semin. Cell Dev. Biol, 60, 19, 10.1016/j.semcdb.2016.07.034 · DOI
  6. Shi, 2011, Functional alteration of PARL contributes to mitochondrial dysregulation in Parkinson's disease, Hum. Mol. Genet, 20, 1966, 10.1093/hmg/ddr077 · DOI
  7. Walder, 2005, The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes, Diabetologia, 48, 459, 10.1007/s00125-005-1675-9 · DOI · Paper page
  8. Paschkowsky, 2016, Alternative processing of the amyloid precursor protein family by rhomboid protease RHBDL4, J. Biol. Chem, 291, 21903, 10.1074/jbc.M116.753582 · DOI · Paper page
  9. Düsterhoft, 2017, Rhomboid proteases in human disease: mechanisms and future prospects, Biochim. Biophys. Acta, 1864, 2200, 10.1016/j.bbamcr.2017.04.016 · DOI
  10. Paschkowsky, 2018, Embedded in the membrane: how lipids confer activity and specificity to intramembrane proteases, J. Membr. Biol, 251, 369, 10.1007/s00232-017-0008-5 · DOI
  11. Urban, 2005, Reconstitution of intramembrane proteolysis in vitro reveals that pure rhomboid is sufficient for catalysis and specificity, Proc. Natl. Acad. Sci. U.S.A, 102, 1883, 10.1073/pnas.0408306102 · DOI
  12. Moin, 2012, Membrane immersion allows rhomboid proteases to achieve specificity by reading transmembrane segment dynamics, Elife, 1, e00173, 10.7554/eLife.00173 · DOI
  13. Urban, 2014, A subset of membrane-altering agents and γ-secretase modulators provoke nonsubstrate cleavage by rhomboid proteases, Cell Rep, 8, 1241, 10.1016/j.celrep.2014.07.039 · DOI
  14. Fleig, 2012, Ubiquitin-dependent intramembrane rhomboid protease promotes ERAD of membrane proteins, Mol. Cell, 47, 558, 10.1016/j.molcel.2012.06.008 · DOI
  15. Wunderle, 2016, Rhomboid intramembrane protease RHBDL4 triggers ER-export and non-canonical secretion of membrane-anchored TGFα, Sci. Rep, 6, 27342, 10.1038/srep27342 · DOI
  16. van Meer, 2008, Membrane lipids: where they are and how they behave, Nat. Rev. Mol. Cell Biol, 9, 112, 10.1038/nrm2330 · DOI · Paper page
  17. Motamed, 2011, Identification of luminal Loop 1 of Scap protein as the sterol sensor that maintains cholesterol homeostasis, J. Biol. Chem, 286, 18002, 10.1074/jbc.M111.238311 · DOI
  18. Brown, 2000, Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans, Cell, 100, 391, 10.1016/S0092-8674(00)80675-3 · DOI · Paper page
  19. Barrett, 2012, The amyloid precursor protein has a flexible transmembrane domain and binds cholesterol, Science, 336, 1168, 10.1126/science.1219988 · DOI · Paper page
  20. Beel, 2008, Structural studies of the transmembrane C-terminal domain of the amyloid precursor protein (APP): does APP function as a cholesterol sensor?, Biochemistry, 47, 9428, 10.1021/bi800993c · DOI
  21. Munter, 2007, GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42, EMBO J, 26, 1702, 10.1038/sj.emboj.7601616 · DOI
  22. Pierrot, 2013, Amyloid precursor protein controls cholesterol turnover needed for neuronal activity, EMBO Mol. Med, 5, 608, 10.1002/emmm.201202215 · DOI
  23. Miller, 2004, The role of cholesterol and statins in Alzheimer's disease, Ann. Pharmacother, 38, 91, 10.1345/aph.1D104 · DOI
  24. Puglielli, 2003, Alzheimer's disease: the cholesterol connection, Nat. Neurosci, 6, 345, 10.1038/nn0403-345 · DOI · Paper page
  25. Wolozin, 2001, A fluid connection: cholesterol and Aβ, Proc. Natl. Acad. Sci. U.S.A, 98, 5371, 10.1073/pnas.101123198 · DOI
  26. Hwang, 2016, A Golgi rhomboid protease Rbd2 recruits Cdc48 to cleave yeast SREBP, EMBO J, 35, 2332, 10.15252/embj.201693923 · DOI
  27. Kim, 2015, Identification of Rbd2 as a candidate protease for sterol regulatory element binding protein (SREBP) cleavage in fission yeast, Biochem. Biophys. Res. Commun, 468, 606, 10.1016/j.bbrc.2015.10.165 · DOI
  28. Goldstein, 1990, Regulation of the mevalonate pathway, Nature, 343, 425, 10.1038/343425a0 · DOI · Paper page
  29. Ferreri, 1992, Increased cellular cholesterol upregulates high density lipoprotein binding to rat luteal cells, Endocrinology, 131, 2059, 10.1210/endo.131.5.1330487 · DOI
  30. Fassbender, 2001, Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo, Proc. Natl. Acad. Sci. U.S.A, 98, 5856, 10.1073/pnas.081620098 · DOI · Paper page
  31. Frears, 1999, The role of cholesterol in the biosynthesis of β-amyloid, Neuroreport, 10, 1699, 10.1097/00001756-199906030-00014 · DOI
  32. Kojro, 2010, Statins and the squalene synthase inhibitor zaragozic acid stimulate the non-amyloidogenic pathway of amyloid-β protein precursor processing by suppression of cholesterol synthesis, J. Alzheimers Dis, 20, 1215, 10.3233/JAD-2010-091621 · DOI
  33. Kojro, 2001, Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10, Proc. Natl. Acad. Sci. U.S.A, 98, 5815, 10.1073/pnas.081612998 · DOI · Paper page
  34. Sidera, 2005, The regulation of β-secretase by cholesterol and statins in Alzheimer's disease, J. Neurol. Sci, 229, 269, 10.1016/j.jns.2004.11.044 · DOI
  35. Cole, 2005, Statins cause intracellular accumulation of amyloid precursor protein, β-secretase-cleaved fragments, and amyloid β-peptide via an isoprenoid-dependent mechanism, J. Biol. Chem, 280, 18755, 10.1074/jbc.M413895200 · DOI
  36. Sakai, 1998, Molecular identification of the sterol-regulated luminal protease that cleaves SREBPs and controls lipid composition of animal cells, Mol. Cell, 2, 505, 10.1016/S1097-2765(00)80150-1 · DOI
  37. Hawkins, 2008, Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals, J. Pharmacol. Exp. Ther, 326, 801, 10.1124/jpet.108.139626 · DOI
  38. Goldstein, 1983, Receptor-mediated endocytosis of low-density lipoprotein in cultured cells, Methods Enzymol, 98, 241, 10.1016/0076-6879(83)98152-1 · DOI
  39. Amemiya-Kudo, 2002, Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promotersof lipogenic and cholesterogenic genes, J. Lipid Res, 43, 1220, 10.1194/jlr.M100417-JLR200 · DOI
  40. Fantini, 2016, A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes, Sci. Rep, 6, 21907, 10.1038/srep21907 · DOI
  41. Baier, 2011, Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor, Sci. Rep, 1, 69, 10.1038/srep00069 · DOI
  42. Li, 1998, Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern, Endocrinology, 139, 4991, 10.1210/endo.139.12.6390 · DOI · Paper page
  43. Gál, 2015, Mutations of the central tyrosines of putative cholesterol recognition amino acid consensus (CRAC) sequences modify folding, activity, and sterol-sensing of the human ABCG2 multidrug transporter, Biochim. Biophys. Acta, 1848, 477, 10.1016/j.bbamem.2014.11.006 · DOI
  44. Bondar, 2009, Rhomboid protease dynamics and lipid interactions, Structure, 17, 395, 10.1016/j.str.2008.12.017 · DOI
  45. Arutyunova, 2017, Activity assays for rhomboid proteases, Methods Enzymol, 584, 395, 10.1016/bs.mie.2016.11.002 · DOI
  46. Das, 2014, Three pools of plasma membrane cholesterol and their relation to cholesterol homeostasis, Elife, 3, e02882, 10.7554/eLife.02882 · DOI · Paper page
  47. Wang, 2015, Cathepsin L mediates the degradation of novel APP C-terminal fragments, Biochemistry, 54, 2806, 10.1021/acs.biochem.5b00329 · DOI
  48. Gbelcová, 2013, The effect of simvastatin on lipid droplets accumulation in human embryonic kidney cells and pancreatic cancer cells, Lipids Health Dis, 12, 126, 10.1186/1476-511X-12-126 · DOI
  49. Kelley, 2015, The Phyre2 web portal for protein modeling, prediction and analysis, Nat. Protoc, 10, 845, 10.1038/nprot.2015.053 · DOI · Paper page
  50. Wang, 2007, The role of L1 loop in the mechanism of rhomboid intramembrane protease GlpG, J. Mol. Biol, 374, 1104, 10.1016/j.jmb.2007.10.014 · DOI
  51. Kelley, 2009, Protein structure prediction on the Web: a case study using the Phyre server, Nat. Protoc, 4, 363, 10.1038/nprot.2009.2 · DOI
  52. Humphrey, 1996, VMD: visual molecular dynamics, J. Mol. Graph, 14, 33, 10.1016/0263-7855(96)00018-5 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
Paschkowsky, S., Recinto, S. J., Young, J. C., Bondar, A.-N., & Munter, L. M.
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2018-10
Volume
293
Issue
40
Pages
15556-15568
ISSN
0021-9258
Cited by
29
References
5
Language
en
Funders
  • Fonds de Recherche du Québec - Santé (FRQS) (Pfizer-FRQS 31288)
  • Government of Canada | Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2015–04645)
  • Canada Foundation for Innovation (CFI) (LOF 32565)
  • Alzheimer Society (PT-58872 and 17–02)
  • Scottish Rite Charitable Foundation of Canada (SRCFC) (16112)
  • Deutsche Forschungsgemeinschaft (DFG) (FUB Excellence Initiative)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review